Nektar Therapeutics

NKTRNASDAQHealthcare● Active

$55.90

$-1.42(-2.47%)

Market Cap$1.1B

P/E Ratio—

52W High$109

52W Low$7.99

Avg Volume1.0M

Open$57.20

Beta1.15

Forecast Market Cap PE Ratio

Nektar Therapeutics（NKTR）股价预测与分析师目标价

华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。

nktr · 股价预测 · 33 位分析师（近3月）· FMP · 更新于 2026年6月8日

分析师评级与共识

基于过去 3 个月内 33 位华尔街分析师

Buy

33 位分析师

共识

评级分布

Strong Buy

Buy

Hold

Sell

Strong Sell

合计: 33 · 买入占比: 66.7%

12 个月目标价

High

$192

Consensus

$150

+167.6% upside

Low

$80.00

Median: $151 · Last Close: $55.90

Nektar Therapeutics（NKTR）的分析师共识为 Buy，基于过去 3 个月内 33 位华尔街分析师的评级。NKTR 的 12 个月平均目标价为 $149.60，相对当前价 $55.90 代表 +167.6% 的潜在上行空间。

12 个月目标价预测

历史收盘价 + 分析师 12 个月目标价预测区间

Historical priceConsensus $150 (167.6%)High $192Low $80

Consensus Target

$149.60

167.6% upside

High Target

$192

243.5%

Low Target

$80

43.1%

Current Price

$55.90

as of today

Based on analyst price targets, the NKTR stock price prediction for the next 12 months ranges from $80 to $192. The consensus NKTR price forecast of $149.60 implies 167.6% upside from the current price of $55.90.

短期股价预测

Bear

算法生成 · 每日更新

Date	Predicted Price	Change	Min	Max
2026-06-09	$53.10	↓ 5.00%	$52.76	$53.44

1-day model range: $52.76–$53.44. Peak: $53.44 (-5.00%).

长期股价预测

⚠️ 在满 252 个交易日历史（IPO/上市时间较短）前不展示长期预测；短期标签页仍可能显示模型输出。

基于技术分析的股价预测

14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明

Market Sentiment

BEARISH

Based on 14 technical indicators

7%29%64%

1Buy

4Neutral

9Sell

RSI (14)14.9Oversold

MACDBEARISH

Refreshes daily from EOD close

Moving Averages · NKTR · Jun 8, 2026

Simple Moving Average (SMA)

MA 5$58.06SELL

MA 10$61.50SELL

MA 20$66.69SELL

MA 50$76.18SELL

MA 100$0.00NEUTRAL

MA 200$0.00NEUTRAL

Current $NKTR · Price above MA = BUY signal

Exponential Moving Average (EMA)

EMA 5$58.45SELL

EMA 10$61.28SELL

EMA 20$66.13SELL

EMA 50$71.26SELL

EMA 100$0.00NEUTRAL

EMA 200$0.00NEUTRAL

Current $NKTR · Price above MA = BUY signal

How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Date	Brokerage	Action	Rating
2026-05-11	Wedbush	Maintains	Neutral→Neutral
2026-05-08	Piper Sandler	Maintains	Overweight→Overweight
2026-04-21	Citigroup	Maintains	Buy→Buy
2026-04-21	Wedbush	Maintains	Neutral→Neutral
2026-04-20	HC Wainwright & Co.	Maintains	Buy→Buy
2026-04-20	BTIG	Maintains	Buy→Buy
2026-03-16	Citigroup	Maintains	Buy→Buy
2026-02-23	B. Riley Securities	Maintains	Buy→Buy
2026-02-10	HC Wainwright & Co.	Maintains	Buy→Buy
2026-02-10	BTIG	Maintains	Buy→Buy

分析师推荐趋势

Buy ratings2 → 1↓ 1

Hold ratings0 → 1↑ +1

Sell ratings0 → 0

NKTR analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.

财务预测：EPS 与营收一致预期

Revenue This Year

$41M

↓ 21.3% YoY

Revenue Next Year

$37M

↓ 10.5% YoY

EPS This Year

$-9.06

EPS Next Year

$-11.07

↑ 22.2% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast NKTR EPS of $-9.06 for the current fiscal year, based on estimates from 7 analysts. The NKTR revenue forecast is $41M for the current year. These are analyst consensus estimates via FMP / S&P Global.

关于预测与目标价

NKTR 股价预测由两类独立数据源支撑：来自 33 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。NKTR 的共识目标价为 $149.60（+167.6% 上行空间），分析师共识为 Buy。

NKTR 的短期预测（明日）为 $53.10（-5.00%）。

Nektar Therapeutics 在 NASDAQ 上市，代码 NKTR。NKTR 在 2027 年的整体展望偏积极，在覆盖分析师中约 67% 对应 Buy 共识。

常见问题答案综合分析师目标价、一致预期及页面展示的模型结果。

常见问题

NKTR 预测 · 8 个问题

根据 33 位华尔街分析师，NKTR 的 12 个月平均目标价为 $149.60，最高 $192.00、最低 $80.00。若有图表，中位目标价可在上方查看。相对当前价 $55.90，隐含约 +167.6% 的上行空间。

NKTR 目标价NKTR 分析师目标价NKTR 12个月目标价目标价 NKTR

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.